Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1131-1140 of 1772 for

Edit search filters
  1. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of A Mindfulness-Based Intervention With A Wearable Wellness Brain Sensing Device In Newly Diagnosed Breast Cancer Patients Undergoing Surgery

    Rochester, MN

  3. MARK 1A Series: Percutaneous Microwave Ablation For Patients With Lung Tumor(s)

    Rochester, MN

  4. A Study Of Pomalidomide, Ixazomib Citrate, And Dexamethasone In Treating Patients With Previously Treated Multiple Myeloma Or Plasma Cell Leukemia

    Rochester, MN

  5. Study Using Curcumin And Piperine In Reducing Inflammation For Ureteral Stent-Induced Symptoms

    Rochester, MN

  6. Trial Of TRC105 And Sorafenib In Patients With HCC

    Jacksonville, FL

  7. Expanded Access Program With Nivolumab (BMS-936558) In Combination With Ipilimumab (Yervoy®) In Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable Or Metastatic Melanoma (CheckMate 218)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Melanoma Relatlimab Nivolumab

    Jacksonville, FL, Rochester, MN

  9. Study Of A Triple Combination Therapy, DTRM-555, In Patients With R/R CLL Or R/R Non-Hodgkin's Lymphomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. OsteoCool Tumor Ablation Post-Market Study

    Rochester, MN

.

Mayo Clinic Footer